BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23490191)

  • 1. Intraocular concentrations of cytokines and chemokines in rhegmatogenous retinal detachment and the effect of intravitreal triamcinolone acetonide.
    Kunikata H; Yasuda M; Aizawa N; Tanaka Y; Abe T; Nakazawa T
    Am J Ophthalmol; 2013 Jun; 155(6):1028-1037.e1. PubMed ID: 23490191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion.
    Kunikata H; Shimura M; Nakazawa T; Sonoda KH; Yoshimura T; Ishibashi T; Nishida K
    Acta Ophthalmol; 2012 Mar; 90(2):162-7. PubMed ID: 20456252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
    Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH
    Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of Detached Retina and Lens Status Influence Intravitreal Protein Expression in Rhegmatogenous Retinal Detachment.
    Pollreisz A; Sacu S; Eibenberger K; Funk M; Kivaranovic D; Zlabinger GJ; Georgopoulos M; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5493-502. PubMed ID: 26284555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
    Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
    Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of Inflammatory Cytokines in the Vitreous Fluid from Patients with Rhegmatogenous Retinal Detachment and Their Correlations with Clinical Features.
    Takahashi S; Adachi K; Suzuki Y; Maeno A; Nakazawa M
    Biomed Res Int; 2016; 2016():4256183. PubMed ID: 28074184
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of intravitreal triamcinolone acetonide injection in scleral buckling surgery for macula-off retinal detachment.
    Mirshahi A; Karkhaneh R; Zamani Amir J; Movassat M; Azadi P
    Ophthalmic Res; 2014; 52(3):160-4. PubMed ID: 25342193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erosive Retinopathy and Retinal Detachment From Depot Intravitreal Triamcinolone Acetonide Injection at the End of Pars Plana Vitrectomy.
    Sisk RA; Patel YP; Foster RE; Petersen MR
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):613-619. PubMed ID: 31671193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
    Ozdemir H; Karacorlu M; Karacorlu SA
    Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection.
    Agawa T; Usui Y; Wakabayashi Y; Okunuki Y; Juan M; Umazume K; Kezuka T; Takeuchi M; Yamauchi Y; Goto H
    Retina; 2014 Sep; 34(9):1811-8. PubMed ID: 24801651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
    Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits.
    Arimura S; Takamura Y; Miyake S; Gozawa M; Iwasaki K; Tomomatsu T; Matsumura T; Inatani M
    Exp Eye Res; 2016 Aug; 149():1-7. PubMed ID: 27296072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Shiragami C; Shiraga F; Kano M; Iida T
    Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
    Chen SD; Sundaram V; Lochhead J; Patel CK
    Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial.
    Gillies MC; McAllister IL; Zhu M; Wong W; Louis D; Arnold JJ; Wong TY
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2322-8. PubMed ID: 20019369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.